Loading search results
PhysioBX
Analysis of the Profile of Patients Diagnosed With Bronchiectasis Referred to the Respiratory Physiotherapy Unit of the Rehabilitation Service in the A Coruña and Cee Health Area: a Retrospective Observational Study.
Sponsor study identifier
Secondary identifiers
OTHER · Comité de Ética de la Investigación de A Coruña-Ferrol
observational
270
1 country
1
Study Start
July 7, 2026
Actual (reported)Primary Completion
October 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 1, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study design: observational, retrospective Population: 270 patients diagnosed with bronchiectasis (BX) treated at the Respiratory Physiotherapy Unit of the Rehabilitation Service of the A Coruña and Cee Health Area. Objective: To determine the profile of patients diagnosed with BX (not due to cystic fibrosis) treated at the Respiratory Physiotherapy Unit of the Rehabilitation Service of the A Coruña and Cee Health Area between 1 January 2022 and 1 March 2026. Hypotheses:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 7, 2026
Actual (reported)July 14, 2026
Actual (reported)July 29, 2026
Actual (reported)October 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 1, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Anthropometric characteristics
Age (years)
Baseline
Anthropometric characteristics
Gender: female/male.
Baseline
Anthropometric characteristics
Height (metres)
Baseline
Anthropometric characteristics
Weight ( kilograms)
Baseline
Anthropometric characteristics
Body mass index (BMI). Weight and height will be combined to report BMI in kg/m\^2.
Pulmonary Rehabilitation Programme
This study analyses a cohort of 270 adult patients from the A Coruña and Cee health district who were diagnosed with bronchiectasis at the Pulmonology Department of A Coruña Hospital via computed tomography and treated at the Respiratory Physiotherapy Unit of the Rehabilitation Department at A Coruña Hospital.
Hospital Marítimo de Oza, Hospital a Coruña, SERGAS
A Coruña, A, 15006, Spain
Lee AL, Hill CJ, McDonald CF, Holland AE. Pulmonary Rehabilitation in Individuals With Non-Cystic Fibrosis Bronchiectasis: A Systematic Review. Arch Phys Med Rehabil. 2017 Apr;98(4):774-782.e1. doi: 10.1016/j.apmr.2016.05.017. Epub 2016 Jun 16.
Martinez-Garcia MA, Maiz L, Olveira C, Giron RM, de la Rosa D, Blanco M, Canton R, Vendrell M, Polverino E, de Gracia J, Prados C. Spanish Guidelines on Treatment of Bronchiectasis in Adults. Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):88-98. doi: 10.1016/j.arbres.2017.07.016. Epub 2017 Nov 9. English, Spanish.
Yolanda Y Sanesteban-Hermida, PT MSc
INIBIC, SERGAS, Universidad A Coruña
Beatriz B Rodriguez-Romero, PT PhD
Universidad A Coruña
Estíbaliz E Díaz-Balboa, PT PhD
Universidad A Coruña
Jacobo J Formigo-Couceiro, Doctor en Rehabilitación
Instituto de Investigacion Biomedica de A Coruna
First Submitted
July 14, 2026
First Posted
July 29, 2026
Study Start
July 7, 2026
Actual (reported)Primary Completion
October 1, 2026
Estimated (date passed)Baseline
Lifestyle habits
* Smoking status: yes/no * Former smoker: yes/no (defined as having given up smoking for ≥ 4 months).
Baseline
Characteristics of the pathological process: aetiology.
Post-infectious, inflammatory, immunological, congenital or other
Baseline
Radiological findings:
Confirmation of the diagnosis using high-resolution computed tomography, type of bronchiectasis and radiological extent.
Baseline
Clinical findings. Modified Medical Research Council Dyspnoea Scale
The Modified Medical Research Council (mMRC) Dyspnoea Scale is a tool for assessing the patient's sensation of breathlessness and is used to classify the severity of dyspnoea into five levels, ranging from zero - which indicates the absence of dyspnoea - to four, which represents severe dyspnoea that limits everyday activities.
Periprocedural.
Microbiological Analysis of Sputum
Types of bacteria and fungi found in sputum.
Periprocedural
Laboratory test.
C-reactive protein (CRP), measured in mg/L
Values recorded in the most recent laboratory test in the medical record at the time the respiratory physical therapy program begins.
Bronchiectasis severity scale: E-FACED
It is a multidimensional tool that enables the stratification of the risk of exacerbations, hospitalisations and mortality. It is valued exacerbations, spirometric data, age, pseudomonas colonisation, computed tomography extent and dyspnoea.Each variable is scored on a dichotomous scale, with a total range of increasing severity from 0 to 9 points, where 0-3 points indicate mild bronchiectasis, 4-6 points moderate bronchiectasis and 7-9 points severe bronchiectasis.
Periprocedural
Pharmacological treatment.
Corticosteroids, antibiotics, inhaled bronchodilators and saline solution.
Periprocedural
Comorbidities.
Bronchial colonisation and other pulmonary complications (sleep apnoea syndrome (OSA)), cardiovascular, neurological, gastrointestinal (hiatal hernia), rheumatic, oncological or osteoarticular conditions.
Baseline
Exacerbations of bronchiectasis
Number of hospital admissions prior to respiratory physiotherapy treatment
The year prior to the start of respiratory physiotherapy treatment
Exacerbations of bronchiectasis
Number of readmissions following respiratory physiotherapy treatment
From the end of treatment up to 1 year later.
Physiotherapy on the ward during hospitalisation
Yes /no
Periprocedural.
Characteristics of physiotherapy treatment. Type of treatment (by duration):
Physiotherapy treatment 1 (8 weeks, rehabilitation protocol comprising education, bronchial clearance, strength training and aerobic exercise): duration (8 weeks, yes/no), interruptions to the programme and the reason for each interruption. Physiotherapy treatment 2 (10 sessions comprising education, bronchial clearance and exercise): interruptions and reason for each interruption. Physiotherapy treatment 3 (1 session comprising education and bronchial clearance).
Periprocedural.
Treatment techniques used in the pulmonary rehabilitation programme (yes/no).
Health education (use of nebulisers.), bronchial clearance sessions, positive pressure exercises (Acapella, Shaker), use of a volumetric spirometer, therapeutic exercise, strength training, aerobic training.
Periprocedural.
Treatment compliance
Non-compliant category based on attendance records and adherence to sessions.
Periprocedural.
Lung function: spirometry.
Spirometry is a respiratory function test that measures respiratory flow rates and volumes, which are useful for the diagnosis and monitoring of respiratory conditions. The spirometry results recorded in the medical records are compared: those taken before and after physiotherapy treatment.
Periprocedural.
Strength of the inspiratory muscles.
Measuring maximum inspiratory pressures (MIP) allows the strength of the inspiratory muscles to be assessed. These are simple, quick and non-invasive measurements. They involve the patient generating the maximum inspiratory pressure, measured in cmH₂O (starting from residual volume), against an occluded system. MIP primarily assesses diaphragmatic strength and is of great clinical utility in the diagnosis and monitoring of conditions affecting the respiratory muscles.
Periprocedural
Strength of the expiratory muscles.
Measuring peak expiratory pressures (MEP) allows the strength of the expiratory muscles to be assessed. These are simple, quick and non-invasive measurements. They involve the patient generating maximum expiratory pressure (from total lung capacity) against an occluded system. MEP is measured in cmH₂O and primarily assesses the strength of the intercostal and abdominal muscles. MEP are of great clinical utility in the diagnosis and monitoring of conditions affecting the respiratory muscles.
Periprocedural
Physical and functional capacity: The six-minute walk test (6MWT)
The six-minute walk test (6MWT) is a functional assessment used to measure exercise capacity and the cardiorespiratory response to exertion under controlled conditions. It involves determining the maximum distance a person can walk on a flat surface over a period of six minutes. In addition, oxygen saturation is measured using pulse oximetry throughout the test. It is widely used to assess tolerance to physical exertion, monitor the progression of various respiratory conditions and estimate the functional prognosis of diseases in a clinical setting.
Periprocedural.
Physical and functional capacity : Sit-to-Stand Test (1STST)
The Sit-to-Stand Test is a test that assesses the functional strength of the lower limbs and involves the person sitting down and standing up from a chair as many times as possible in 1 minute .
Periprocedural.
Physical and functional capacity : submaximal cycle ergometer test.
A submaximal cycle ergometer test is a stress test carried out on a stationary bicycle in which the patient is not required to exert themselves to their maximum capacity. The aim is to assess the cardiovascular, respiratory and functional responses during moderate-intensity exercise. The following are measured: watts, the duration of the test and the reason for failure.
Periprocedural.
Physical and functional capacity: submaximal test on a treadmill
A submaximal treadmill test is a stress test carried out on a treadmill in which the patient walks at a moderate intensity, without reaching maximum exertion. Its aim is to assess the response to exercise and functional capacity in a safe manner. The duration of the test, the angle of inclination reached and the reason for giving up are measured.
Periprocedural
Clinical findings
An assessment is made as to whether the patient is experiencing a cough, sputum production or haemoptysis (yes/no) at the time of physiotherapy treatment.
Periprocedural.
Contact the study team to confirm eligibility.
Herrero-Cortina B, Lee AL, Oliveira A, O'Neill B, Jacome C, Dal Corso S, Poncin W, Munoz G, Inal-Ince D, Alcaraz-Serrano V, Reychler G, Bellofiore A, Posthumus A; Patient representative; Tonia T, Chalmers JD, Spinou A. European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis. Eur Respir J. 2023 Jul 20;62(1):2202053. doi: 10.1183/13993003.02053-2022. Print 2023 Jul.
Martinez-Garcia MA, Athanazio RA, Giron R, Maiz-Carro L, de la Rosa D, Olveira C, de Gracia J, Vendrell M, Prados-Sanchez C, Gramblicka G, Corso Pereira M, Lundgren FL, Fernandes De Figueiredo M, Arancibia F, Rached SZ. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017 Jan 18;12:275-284. doi: 10.2147/COPD.S121943. eCollection 2017.
Martí-Romeu JD, Vendrell Relat M, coords. Manual SEPAR de procedimientos 27: Técnicas manuales e instrumentales para el drenaje de secreciones bronquiales en el paciente adulto [Internet]. Barcelona: Respira-Fundación Española del Pulmón-SEPAR. Disponible en: https://issuu.com/separ/docs/manual__separ_27_tecnicas_manuales_/1
Burgos F, Casan P, coordinadores. Manual SEPAR de procedimientos. Módulo 4. Procedimientos de evaluación de la función pulmonar II. Barcelona: Publicaciones Permanyer; 2004. 144 p.
Güell Rous MR, Díaz Lobato S, Rodríguez Trigo G, Morante Vélez F, San Miguel M, Cejudo P, et al. Rehabilitación respiratoria. ArchBronconeumol [Internet]. 2014 Aug 1 [cited 2022 Jun 9];50(8):332-44. Disponible en: https://www.archbronconeumol.org/en-rehabilitacion-respiratoria-articulo-S0300289614000878
Calvo JS, Bellido VG, Sousa JLA. Sistema respiratorio: métodos, fisioterapia clínica y afecciones para fisioterapeutas. Editorial Médica Panamericana; 2018.
Marina M Blanco-Aparicio, Doctora en Neumología
Sergas
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 1, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
July 29, 2026
Record last verified: 2026-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: